Charting the Future of Neuroblastoma Treatment at SIOPEN Meeting – St. Anna Children’s Cancer Research Institute
St. Anna Children’s Cancer Research Institute made the following post on LinkedIn:
“Charting the Future of Neuroblastoma Treatment at SIOPEN Meeting
The SIOPEN Translational Research Meeting wraps up with a culmination of insights and strategies for new drug development. From a comprehensive NDD strategy review to updates on novel treatment options based on preclinical data, the day showcased the relentless pursuit of innovative therapies. The session concluded with a visionary look into trial fast-tracking proposals, paving the way for the future of neuroblastoma treatment.
We thank all participants for their contribution, allowing insightful discussions and hope to see you again soon in Vienna.”
Read further.
Source: St. Anna Children’s Cancer Research Institute/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023